i.v. recombinant human C1 inhibitor

DRUG2 trials

Sponsors

Pharming Technologies B.V.

Conditions

Genetic Disorders

Phase 2

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

CompletedNCT00261053

Pharming Technologies B.V.Genetic Disorders

Start: 2003-06-30End: 2005-12-31Updated: 2013-04-25

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

CompletedNCT00262288

Pharming Technologies B.V.Genetic Disorders

Start: 2004-04-30End: 2007-01-31Updated: 2013-02-22